Trump just signed an Executive Order that has Fauci allies scrambling

President Donald Trump took decisive action Monday with an Executive Order that will put an end to dangerous gain-of-function research funding in China.
The move has left the medical establishment in shock.
And Trump just signed an Executive Order that has Fauci allies scrambling.
Trump takes on dangerous research
President Trump signed an Executive Order on May 5 to crack down on the type of dangerous research that many believe caused the COVID-19 pandemic
The order directly targets gain-of-function research – the controversial practice of enhancing pathogens to make them more transmissible or deadly, allegedly to study how to combat them.
“Dangerous gain-of-function research on biological agents and pathogens has the potential to significantly endanger the lives of American citizens,” the Executive Order states.
Trump’s order specifically calls out the Biden-Harris administration for its reckless approach to this potentially catastrophic research.
“The Biden Administration allowed dangerous gain-of-function research within the United States with insufficient levels of oversight,” the order reads. “It also actively approved, through the National Institutes of Health, Federal life-science research funding in China and other countries where there is limited United States oversight.”
This criticism strikes at the heart of controversies surrounding Dr. Anthony Fauci’s NIAID, which provided funding to EcoHealth Alliance that ultimately reached the Wuhan Institute of Virology in China – the lab many believe was the source of the COVID-19 pandemic.
Immediate action to protect Americans
The President’s order doesn’t just talk tough – it takes immediate action.
It directs relevant agencies to “immediately end Federal funding of dangerous gain-of-function research conducted by foreign entities in countries of concern (e.g., China)” and to suspend federally funded gain-of-function research in the United States until proper safeguards are in place.
This represents a complete reversal of the Biden-Harris approach, which continued funding potentially dangerous research despite the lessons of the COVID-19 pandemic.
“This recklessness, if unaddressed, may lead to the proliferation of research on pathogens (and potential pathogens) in settings without adequate safeguards, even after COVID-19 revealed the risk of such practices,” the order explains.
Real consequences for violations
Unlike previous administrations’ weak oversight, Trump’s order puts real teeth into enforcement.
Researchers or institutions found violating these policies could face “immediate revocation of ongoing Federal funding, and up to a 5-year period of ineligibility for Federal life-sciences grant funds.”
The order also creates a reporting system to increase transparency, requiring research institutions to report dangerous gain-of-function research, including research supported by non-federal funding.
For years, critics have warned that gain-of-function research posed an unacceptable risk of causing a pandemic through a lab leak. Now, Trump is finally taking action to address this threat.
The Biden-Fauci connection
This Executive Order represents a direct challenge to the scientific establishment that was closely aligned with Dr. Anthony Fauci during the pandemic.
Under Fauci’s leadership at NIAID, U.S. taxpayer dollars flowed to the very type of research that may have caused the COVID-19 pandemic. The Biden-Harris administration continued this approach despite mounting evidence of its dangers.
Trump’s order specifically criticizes the Biden administration’s 2024 policies on dual-use research and nucleic acid synthesis screening as “inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.”
The President has long maintained that COVID-19 likely originated from a lab leak at the Wuhan Institute of Virology and has consistently pushed for transparency in investigating its origins.
America First approach
While protecting Americans from dangerous research, the order emphasizes that it will not impede America’s leadership in biotechnology.
“My Administration will balance the prevention of catastrophic consequences with maintaining readiness against biological threats and driving global leadership in biotechnology, biological countermeasures, biosecurity, and health research,” Trump states in the order.
This represents the President’s America First approach – ensuring research benefits American citizens without jeopardizing national security or public health.
With this Executive Order, President Trump has taken a significant step toward preventing another pandemic caused by reckless laboratory practices while ensuring America remains at the forefront of beneficial biomedical research.
The medical establishment aligned with Fauci’s approach is now on notice – the days of dangerous gain-of-function research with minimal oversight are over.